4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 98% LCMS

cas: 606-58-6 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 98% LCMS (CAS 606-58-6) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 5mg, 50mg, 100mg, 250mg, 1g. Oferty producentów: Fluorochem.

• 2D
• 3D

4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile (CAS 606-58-6) to związek chemiczny o wzorze sumarycznym C12H13N5O4 i masie molowej 291.26 g/mol. Nazwa systematyczna IUPAC: 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile. InChIKey: XOKJUSAYZUAMGJ-WOUKDFQISA-N.

Dane identyfikacyjne

Wzór sumaryczny	C12H13N5O4
Masa molowa	291.26 g/mol
Nazwa IUPAC	4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile
InChIKey	XOKJUSAYZUAMGJ-WOUKDFQISA-N
SMILES	C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C#N

Dane obliczone przez PubChem (NCBI)

Synonimy: TOYOCAMYCIN, Vengicide, Uramycin B, Antibiotic 1037, Siromycin, Cyanotubericidin, Ahygroscopin-B, 7-Deaza-7-cyanoadenosine, Antibiotic E212, Unamycin-B

Powiązane formy tego związku

4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile C₁₂H₁₃N₅O₄

Izomery (ten sam wzór sumaryczny)

(2R,3S,4R,5R)-2-(hydroxymethyl)-5-imidazo[2,1-f]purin-3-yloxolane-3,4-diol C₁₂H₁₃N₅O₄

2-[[[2-(methoxymethyl)-1,2,4-triazol-3-yl]amino]carbamoyl]benzoic acid C₁₂H₁₃N₅O₄

(2R,3R,4S,5R)-2-(5-deuterio-4-imino-1H-pyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile C₁₂H₁₃N₅O₄

(2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile C₁₂H₁₃N₅O₄

(2S,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile C₁₂H₁₃N₅O₄

(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile C₁₂H₁₃N₅O₄

1-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5H-imidazo[2,1-b]purin-4-one C₁₂H₁₃N₅O₄

methyl N-[5-(3,6-dihydro-2H-pyridin-1-yl)-2-oxo-[1,2,4]oxadiazolo[2,3-a]pyrimidin-7-yl]carbamate C₁₂H₁₃N₅O₄

3-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4H-imidazo[1,2-a]purin-9-one C₁₂H₁₃N₅O₄

(2R,3R,4S,5R)-2-(6-amino-2-ethynylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol C₁₂H₁₃N₅O₄

2-amino-7-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile C₁₂H₁₃N₅O₄